Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  MEDNAX Inc    MD

Delayed Quote. Delayed  - 06/30 10:04:12 pm
72.43 USD   +1.36%
06/24 BRIEF : 3 S. Florida businesses on Forbes' 'Most Innovative Companie..
06/23 MEDNAX : Cross Keys Capital Completes Sale of Westchester Anesthesio..
06/22 MEDNAX : Medical Imaging Leaders Tap IBM and Watson to Tackle Cancer..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Sales2 1542 439-3 1613 4723 816
Operating income (EBITDA)492559654693760818
Operating profit (EBIT)452513632607670761
Pre-Tax Profit (EBT)448-----
Net income281317-349388435
P/E ratio19,220,820,019,117,315,6
EPS ( $ )2,783,183,583,734,144,60
Dividend per Share ( $ )------
Yield------
Reference price ( $ )53.3866.1171.6671.4671.4671.46
Announcement Date01/30/2014
11:00am
01/29/2015
11:00am
----
Finances - Leverage
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Debt-515-1 221980-
Finance10,4-----
Operating income (EBITDA)492559654693760818
Leverage
(Debt/EBITDA)
-0,92x-1,76x1,29x-
Capital Expenditure15,618,127,137,030,835,0
Book Value Per Share (BVPS)23,2 $22,6 $25,9 $29,2 $32,4 $34,8 $
Cash Flow per Share4,02 $4,23 $3,92 $5,32 $5,66 $5,80 $
Announcement Date01/30/2014
11:00am
01/29/2015
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 6 640 M$ -
Entreprise Value (EV) 7 861 M$ 7 620 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 19,1x 17,3x
Capitalization / Revenue 2,10x 1,91x
EV / Revenue 2,49x 2,19x
EV / EBITDA 11,3x 10,0x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,45x 2,21x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 19,2% 19,3%
operating Leverage (Delta EBIT / Delta Sales) - 1,06x
Net Margin (Net Profit / Revenue) 11,1% 11,2%
ROA (Net Profit / Asset) 7,40% 7,60%
ROE (Net Profit / Equities) 14,0% 13,8%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   1,17% 0,89%
Cash Flow / Sales 15,6% 15,1%
Capital Intensity (Assets / Sales) 1,49x 1,47x
Financial Leverage (Net Debt / EBITDA) 1,76x 1,29x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend